InvitroCue Ltd (IVQ):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InvitroCue Ltd (IVQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12361
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd, is a provider of bio-analytic solutions. The company provides digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image archiving, among others. It provides cell-based services to pharmaceutical and cosmetics companies for ingredients, drugs, compounds and vaccine discovery. InvitroCue offers solutions in fields of in vitro drug metabolism and pharmacokinetic, in vitro toxicology and digital pathology. The company also offers image analytics services for liver disease applications. It has operations in Australia, Singapore and China. InvitroCue is headquartered in Sydney, New South Wales, Australia.

InvitroCue Ltd (IVQ) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InvitroCue Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InvitroCue Ltd, Medical Devices Deals, 2012 to YTD 2018 9
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
InvitroCue Enters into Research Agreement with Garvan Institute of Medical Research 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
InvitroCue Enters into Agreement With QIAGEN Suzhou Translational Medicine 13
National Cancer Centre Singapore to Enter into Research Agreement with InvitroCue 14
Equity Offering 15
Invitrocue Raises USD1 Million in Private Placement of Shares 15
Invitrocue Raises USD1 Million in Private Placement of Shares 16
InvitroCue Ltd – Key Competitors 17
InvitroCue Ltd – Key Employees 18
InvitroCue Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Jul 24, 2017: Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment 20
Jul 20, 2017: InvitroCue and Genome Institute of Singapore establish joint innovation laboratory for the development of in vitro cancer models 21
Corporate Communications 22
Nov 19, 2018: Invitrocue names Dr. Andreas Lindner as CEO of Europe and professor David Waugh as senior advisor 22
Oct 23, 2018: Invitrocue names Dr. Gary W. Pace as an independent non-executive director 23
Sep 28, 2017: InvitroCue announces appointments to management team 24
Legal and Regulatory 25
Aug 29, 2017: IVQ receives award from Singapore government IP office 25
Product News 26
May 22, 2017: Invitrocue Expands Into In-Vitro Skin And Wound Healing Assays 26
Jan 18, 2018: Invitrocue further validates its Onco-PDO technology platform through the successful growth of 14 liver cancer organoids 27
Other Significant Developments 28
Apr 30, 2018: Invitrocue: Appendix 4C, Quarterly Business Update 28
Jan 31, 2018: InvitroCue: Appendix 4C, Quarterly Business Update & Investor Calls 29
Jul 31, 2017: Invitrocue: Appendix 4C – Quarterly Cash Flow Report and Business Update 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
InvitroCue Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InvitroCue Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InvitroCue Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
InvitroCue Ltd, Medical Devices Deals, 2012 to YTD 2018 9
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InvitroCue Enters into Research Agreement with Garvan Institute of Medical Research 11
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 12
InvitroCue Enters into Agreement With QIAGEN Suzhou Translational Medicine 13
National Cancer Centre Singapore to Enter into Research Agreement with InvitroCue 14
Invitrocue Raises USD1 Million in Private Placement of Shares 15
Invitrocue Raises USD1 Million in Private Placement of Shares 16
InvitroCue Ltd, Key Competitors 17
InvitroCue Ltd, Key Employees 18
InvitroCue Ltd, Other Locations 19
InvitroCue Ltd, Subsidiaries 19

List of Figures
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InvitroCue Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InvitroCue Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[InvitroCue Ltd (IVQ):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spark Infrastructure Group:企業の発電所・SWOT分析2018
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Rex International Holding Ltd (5WH):企業の財務・戦略的SWOT分析
    Summary Rex International Holding Ltd (Rex International), formerly Rex International Holding Pte Ltd is an independent exploration and production oil company. The company develops oil and gas properties across Singapore. It operates substantial oil and gas exploration concessions in the UAE, Oman, …
  • Oberg Industries Inc:企業の戦略的SWOT分析
    Oberg Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nevada Gold & Casinos, Inc.:企業の戦略・SWOT・財務情報
    Nevada Gold & Casinos, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nevada Gold & Casinos, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oglethorpe Power Corporation:発電所・企業SWOT分析
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • The Ambassador Hotel Co. Ltd.:企業の戦略・SWOT・財務情報
    The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cimarex Energy Co (XEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Cimarex Energy Co (Cimarax) is an independent upstream oil and natural gas company. It carries out the exploration and production of crude oil, natural gas and natural gas liquids (NGLs). The company’s operations are concentrated in two main areas namely the Mid-Continent region consisting o …
  • C&C Group plc:戦略・SWOT・企業財務分析
    C&C Group plc - Strategy, SWOT and Corporate Finance Report Summary C&C Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mapfre SA (MAP):企業の財務・戦略的SWOT分析
    Mapfre SA (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Buongiorno SpA:企業の戦略的SWOT分析
    Buongiorno SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Methodist Le Bonheur Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Methodist Le Bonheur Healthcare (Methodist Healthcare) is a healthcare service provider that offers patient care services. The center offers home health services through its hospitals. Its services include invasive spine surgery, education and counseling, cancer treatment and support, infusi …
  • Ctrip.Com International Ltd
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Shanghai Medicilon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Medicilon Inc (Medicilon) is a drug discovery company that offers integrated services across biology, preclinical, chemistry, and drug discovery processes. The company provides chemistry services such as process development, medicinal chemistry, synthesis chemistry, and analytical c …
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Pharmsynthez (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmsynthez is a pharmaceutical company that manufactures and markets generic active pharmaceutical ingredients. The company offers production and sales of both officinal medicines (original OM) and active pharmaceutical ingredients (API). It offers drugs such as vazostenon, glaumax, cathal …
  • First Electric Cooperative Corporation:企業の戦略的SWOT分析
    First Electric Cooperative Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Polyplus-Transfection SA-製薬・医療分野:企業M&A・提携分析
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops its RNA interference such as STICKY SIRNA and SIRNAPLUS for invivo research. …
  • Kina Petroleum Ltd (KPL)-石油・ガス分野:企業M&A・提携分析
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆